{"title": "Riboflavin: MedlinePlus Supplements", "author": null, "url": "https://medlineplus.gov/druginfo/natural/957.html", "hostname": "medlineplus.gov", "description": "Riboflavin is vitamin B2. It is widely found in both plants and animals including milk, meat, eggs, nuts, enriched flour, and green vegetables.", "sitename": "Medlineplus", "date": "2021-06-09", "cleaned_text": "What is it? Riboflavin is a B vitamin. It is involved in many processes in the body and is necessary for normal cell growth and function. It can be found in certain foods such as milk, meat, eggs, nuts, enriched flour, and green vegetables. Riboflavin is frequently used in combination with other B vitamins in vitamin B complex products. Some people take riboflavin by mouth to prevent low levels of riboflavin (riboflavin deficiency) in the body, for various types of cancer, and for migraine headaches. It is also taken by mouth for acne, muscle cramps, burning feet syndrome, carpal tunnel syndrome, and blood disorders such as congenital methemoglobinemia and red blood cell aplasia. Some people use riboflavin for eye conditions including eye fatigue, cataracts, and glaucoma. Some people also take riboflavin by mouth to maintain healthy hair, skin, and nails, to slow aging, for canker sores, multiple sclerosis, memory loss including Alzheimer's disease, high blood pressure, burns, liver disease, and sickle cell anemia. Some people take riboflavin by mouth to prevent low levels of riboflavin (riboflavin deficiency) in the body, for various types of cancer, and for migraine headaches. It is also taken by mouth for acne, muscle cramps, burning feet syndrome, carpal tunnel syndrome, and blood disorders such as congenital methemoglobinemia and red blood cell aplasia. Some people use riboflavin for eye conditions including eye fatigue, cataracts, and glaucoma. Some people also take riboflavin by mouth to maintain healthy hair, skin, and nails, to slow aging, for canker sores, multiple sclerosis, memory loss including Alzheimer's disease, high blood pressure, burns, liver disease, and sickle cell anemia. How effective is it? Natural Medicines Comprehensive Database rates effectiveness based on scientific evidence according to the following scale: Effective, Likely Effective, Possibly Effective, Possibly Ineffective, Likely Ineffective, Ineffective, and Insufficient Evidence to Rate. The effectiveness ratings for RIBOFLAVIN are as follows: Effective for... - Preventing and treating low riboflavin levels (riboflavin deficiency). In adults and children who have too little riboflavin in their body, taking riboflavin by mouth can increase levels of riboflavin in the body. Possibly effective for... - Cataracts.People who eat more riboflavin as part of their diet seem to have a lower risk of developing cataracts. Also, taking supplements containing riboflavin plus niacin seems to help prevent cataracts. - High amounts of homocysteine in the blood (hyperhomocysteinemia). Taking riboflavin by mouth for 12 weeks decreases levels of homocysteine by up to 40% in some people. Also, taking riboflavin along with folic acid and pyridoxine seems to lower homocysteine levels by 26% in people with high homocysteine levels caused by drugs that are used to prevent seizures. - Migraine headaches. Taking high-dose riboflavin by mouth seems to reduce the number of migraine headache attacks, by about 2 attacks per month. Taking riboflavin in combination with other vitamin sand minerals seems to also reduce the amount of pain experienced during a migraine. Possibly ineffective for... - Stomach cancer. Taking riboflavin along with niacin does help prevent gastric cancer. - Malnutrition caused by too little protein in the diet (kwashiorkor). Some research suggests that taking riboflavin, vitamin E, selenium, and N-acetyl cysteine by mouth does not reduce fluid, increase height or weight, or decrease infections in children at risk for kwashiorkor. - Lung cancer. Taking riboflavin by mouth along with niacin does not help prevent lung cancer. - Malaria. Taking riboflavin along with iron, thiamine, and vitamin C by mouth, does not reduce the number or seriousness of malaria infections in children at risk of being exposed to malaria. - High blood pressure during pregnancy (pre-eclampsia). In women that are 4 months pregnant, starting to take riboflavin by mouth does reduce the risk of pre-eclampsia during pregnancy. Insufficient evidence to rate effectiveness for... - Lactic acidosis (a serious blood-acid imbalance) in people with acquired immunodeficiency syndrome (AIDS). Early research shows that taking riboflavin by mouth might by helpful for treating lactic acidosis caused by drugs called nucleoside analog reverse transcriptase inhibitors (NRTIs) in patients with acquired immunodeficiency syndrome (AIDS). - Cervical cancer. Increasing intake of riboflavin from dietary and supplement sources, along with thiamine, folic acid, and vitamin B12, might decrease the risk of developing cervical cancer. - Cancer of the food pipe (esophageal cancer). Research on the effects of riboflavin for preventing esophageal cancer is conflicting. Some research shows that taking riboflavin by mouth may decrease the risk of getting esophageal cancer, while other research shows that it has no effect. - High blood pressure. Early research shows that taking riboflavin by mouth in certain patients at higher risk of high blood pressure due to genetic differences may lower blood pressure when used in addition to prescribed blood pressure medications. - Liver cancer. Early research shows that taking riboflavin and niacin by mouth might reduce the risk of liver cancer in people less than 55 years-old. However, it does not seem to reduce the risk of liver cancer in older people. - Multiple sclerosis. Early research shows that taking riboflavin by mouth for 6 months does not improve disability in patients with multiple sclerosis. - White patches inside the mouth (oral leukoplakia). Early research shows that low levels of riboflavin in the blood are linked with an increased risk of oral leukoplakia. However, taking riboflavin supplements by mouth for 20 months does not seem to prevent or treat oral leukoplakia. - Iron deficiency during pregnancy. Early research shows that taking riboflavin, iron, and folic acid by mouth does not increase iron levels in pregnant women more than taking just iron and folic acid. - Sickle cell disease. Early research shows that taking riboflavin by mouth for 8 weeks increases iron levels in people with low iron levels due to sickle cell disease. - Stroke. Early research shows that taking riboflavin and niacin by mouth does not prevent stroke-related death in people at risk for stroke. - Acne. - Aging. - Boosting the immune system. - Canker sores. - Maintaining healthy skin and hair. - Memory loss including Alzheimer's disease. - Muscle cramps. - Other conditions. How does it work? Riboflavin is required for the proper development of many things in the body including the skin, lining of the digestive tract, blood cells, and brain function. Are there safety concerns? Riboflavin is LIKELY SAFE for most people when taken by mouth. In some people, riboflavin can cause the urine to turn a yellow-orange color. It may also cause diarrhea. Pregnancy and breast-feeding: Riboflavin is LIKELY SAFE when taken by mouth and used appropriately for pregnant or breast-feeding women. The recommended amounts are 1.4 mg per day for pregnant women and 1.6 mg per day in breast-feeding women. Riboflavin is POSSIBLY SAFE when taken by mouth in larger doses, short-term. Some research shows that riboflavin is safe when taken at a dose of 15 mg once every 2 weeks for 10 weeks. Hepatitis, Cirrhosis, Billary obstruction: Riboflavin absorption is decreased in people with these conditions. Special precautions & warnings:Children: Riboflavin is LIKELY SAFE for most children when taken by mouth in appropriate amounts as recommended by the Food and Nutrition Board for the National Institute of Medicine (see dosing section below). Pregnancy and breast-feeding: Riboflavin is LIKELY SAFE when taken by mouth and used appropriately for pregnant or breast-feeding women. The recommended amounts are 1.4 mg per day for pregnant women and 1.6 mg per day in breast-feeding women. Riboflavin is POSSIBLY SAFE when taken by mouth in larger doses, short-term. Some research shows that riboflavin is safe when taken at a dose of 15 mg once every 2 weeks for 10 weeks. Hepatitis, Cirrhosis, Billary obstruction: Riboflavin absorption is decreased in people with these conditions. Are there interactions with medications? - Antibiotics (Tetracycline antibiotics) - Riboflavin might decrease the amount of tetracyclines that the body can absorb. Taking riboflavin along with tetracyclines might decrease the effectiveness of tetracyclines. To avoid this interaction, take riboflavin 2 hours before or 4 hours after taking tetracyclines. tetracyclines include demeclocycline - Drying medications (Anticholinergic drugs) - Some drying medications can affect the stomach and intestines. Taking these drying medications with riboflavin (vitamin B2) can increase the amount of riboflavin that is absorbed in the body. But it's not known if this interaction is important. Some of these drying medications include atropine, scopolamine, and some medications used for allergies (antihistamines), and for depression (antidepressants). - Medications for depression (Tricyclic antidepressants) - Some medications for depression can decrease the amount of riboflavin in the body. This interaction is not a big concern because it only occurs with very large amounts of some medications for depression. Some medications used for depression include amitriptyline (Elavil) or imipramine (Tofranil, Janimine), and others. - Phenobarbital (Luminal) - Riboflavin is broken down by the body. Phenobarbital might increase how quickly riboflavin is broken down in the body. It is not clear if this interaction is significant. - Probenecid (Benemid) - Probenecid (Benemid) can increase how much riboflavin is in the body. This might cause there to be too much riboflavin in the body. But it's not known if this interaction is a big concern. Are there interactions with herbs and supplements? - Blond psyllium - Psyllium reduces absorption of riboflavin from supplements in healthy women. It isn't clear whether this occurs with dietary riboflavin, or whether it's really important to health. - Boron - A form of boron, called boric acid, can reduce the solubility of riboflavin in water. This might reduce the absorption of riboflavin. - Folic acid - In people with a condition called methylenetetrahydrofolate reductase (MTHFR) deficiency, taking folic acid might make riboflavin deficiency worse. Folic acid might lower blood levels of riboflavin in people with this condition. - Iron - Riboflavin supplements may improve the way iron supplements work in some people who don't have enough iron. This effect is probably important only in people with riboflavin deficiency. Are there interactions with foods? - Food - Absorption of riboflavin supplements may be increased when taken with food. What dose is used? The following doses have been studied in scientific research: ADULTS BY MOUTH: BY MOUTH: ADULTS BY MOUTH: - General: The recommended dietary allowance (RDA) of riboflavin for adults is 1.3 mg per day for males, 1.1 mg per day for women, 1.4 mg per day for pregnant females, and 1.6 mg per day for lactating women. There is no daily Upper Intake Levels (UL) for riboflavin, which is the highest level of intake that is likely to pose no risk of adverse effects. - For preventing and treating low levels of riboflavin (riboflavin deficiency): Riboflavin 5-30 mg daily has been used. - For cataracts: A combination of riboflavin 3 mg plus niacin 40 mg daily for 5-6 years has been used. - For high levels of homocysteine in the blood): Riboflavin 1.6 mg daily for 12 weeks has been used. A combination containing 75 mg of riboflavin, 0.4 mg of folic acid, and 120 mg of pyridoxine daily for 30 days has also been used. - For migraine headaches: The most common dose is riboflavin 400 mg daily for at least three months. A specific product (Dolovent; Linpharma Inc., Oldsmar, FL ) dosed at two capsules in morning and two capsules in the evening for 3 months has also been used. This dose provides a total of riboflavin 400 mg, magnesium 600 mg, and coenzyme Q10 150 mg per day. BY MOUTH: - General: The recommended dietary allowance (RDA) of riboflavin is 0.3 mg per day for infants up to 6 months old, 0.4 mg per day for infants 6-12 months old, 0.5 mg per day for children 1-3 years old, 0.6 mg per day for children 4-8 years old, 0.9 mg per day for children 9-13 years old, 1.3 mg per day for males 14-18 years old, and 1.0 mg per day for females 14-18. There is no daily Upper Intake Levels (UL) for riboflavin, which is the highest level of intake that is likely to pose no risk of adverse effects. - For preventing and treating low levels of riboflavin (riboflavin deficiency): Riboflavin 2 mg once, then 0.5-1.5 mg daily for 14 days has been used. Riboflavin 2-5 mg daily for up to two months has been used. Riboflavin 5 mg five days per week for up to one year has also been used. Other names B Complex Vitamin, Complexe de Vitamina B2, Vitamine B2, Vitamine G. Methodology To learn more about how this article was written, please see the Natural Medicines Comprehensive Database [methodology](https://medlineplus.gov/druginfo/natural/methodology.html). References - Dietary reference intakes (DRIs): estimated average requirements. Food and Nutrition Board, Institute of Medicine, National Academics. https://www.nal.usda.gov/sites/default/files/fnic_uploads//recommended_intakes_individuals.pdf Accessed July 24, 2017. - Wilson CP, McNulty H, Ward M, et al. Blood pressure in treated hypertensive individuals with the MTHFR 677TT genotype is responsive to intervention with riboflavin: findings of a targeted randomized trial. Hypertension. 2013;61:1302-8. [View abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=23608654&dopt=Abstract). - Wilson CP, Ward M, McNulty H, et al. Riboflavin offers a targeted strategy for managing hypertension in patients with the MTHFR 677TT Group. Improvement migraine with a proprietary supplement containing riboflavin, magnesium and Q10: a randomized, et al. Riboflavin supplementation to patients with multiple sclerosis does not improve disability status nor is riboflavin supplementation correlated A. V. Indian J Med Res 1998;108:182-190. [View abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9863274&dopt=Abstract). - Pascale, J. A., Mims, L. C., Greenberg, M. H., Gooden, D. S., and Chronister, E. H., Eaton-Evans, J., Coulter, J., McCartney, H., and Strain, J. J. Riboflavin and vitamin B-6 intakes and status and biochemical response to riboflavin [View abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9701198&dopt=Abstract). - Sammon, A. M. and Alderson, D. Diet, reflux and the development of squamous cell carcinoma of the oesophagus in Africa. Br J Surg. 1998;85:891-896. [View abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9692558&dopt=Abstract). and Sharma, S. Nutritional status of the elderly. Indian J Med Res 1997;106:340-348. [View abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9361467&dopt=Abstract). - Spirichev, V. B., Kodentsova, V. M., V. A., Vrzhesinskaia, O. A., Sokol'nikov, A. A., Blazhevvich, N. V., and Beketova, N. A. [Vitamin status of the population from regions suffering from the accident at the Chernobyl power plant, and its correction with multivitamins \"Duovit\" and \"Undevit\" Francaschi, S., Negri, E., and Zleglar, R. Selected micronutrient intake and thyroid carcinoma risk. Cancer 6-1-1997;79:2186-2192. [View abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9179066&dopt=Abstract). - Kodentsova, V. M., Pustograev, N. N., O. A., Kharitonchik, L. A., Pereverzeva, O. G., Iakushina, L. M., Trofimenko, L. S., and Spirichev, V. B. [Comparison of metabolism of water-soluble vitamins in healthy children and in children with insulin-dependent diabetes mellitus depending upon the level of vitamins in the diet]. Vopr.Med Khim. 1996;42:153-158. [View abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9148603&dopt=Abstract). - Wynn, M. and Wynn, A. Can improved diet contribute to the prevention of cataract? Nutr Health 1996;11:87-104. [View abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8994232&dopt=Abstract). - Ito, K. Porcelli, P. J., Adcock, E. W., DelPaggio, D., Swift, L. L., and Greene, H. L. Plasma and urine riboflavin and pyridoxine concentrations abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8856580&dopt=Abstract). - Zempleni, J., Galloway, J. R., and McCormick, D. B. The identification and kinetics of 7 alpha-hydroxyriboflavin (7-hydroxymethylriboflavin) in blood plasma from humans following oral administration of riboflavin supplements. Int J Vitam.Nutr Res 1996;66:151-157. [View abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8843991&dopt=Abstract). - Williams, P. G. Vitamin retention in cook/hot-hold hospital food-services. J Am Diet.Assoc. 1996;96:490-498. [View abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8621875&dopt=Abstract). - Zempleni, J., Galloway, J. R., and McCormick, D. B. Pharmacokinetics of orally and intravenously administered riboflavin in healthy J and Saint-Martin, B. [Vitamin and mineral deficiency in Mexico. A critical review of the state of the art. II. Vitamin deficiency]. Salud Publica Mex. 1995;37:452-461. [View abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8600562&dopt=Abstract). - Powers, H. J. Riboflavin-iron interactions with particular emphasis on the gastrointestinal tract. Proc.Nutr Soc 1995;54:509-517. [View abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8524897&dopt=Abstract). - Heseker, H. and Kubler, W. Chronically increased vitamin intake and vitamin status of healthy men. Nutrition 1993;9:10-17. [View abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8467105&dopt=Abstract). - Igbedioh, S. O. Undernutrition in Nigeria: dimension, causes and remedies for alleviation in a changing socio-economic environment. Nutr Health 1993;9:1-14. [View abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8414269&dopt=Abstract). - Ajayi, O. A., George, B. O., and Ipadeola, T. Clinical trial of riboflavin in sickle cell disease. East Afr.Med J 1993;70:418-421. [View - Zaridze, Chemoprevention of oral leukoplakia and chronic esophagitis in an area of high incidence of oral and esophageal cancer. Ann.Epidemiol 1993;3:225-234. [View abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8275193&dopt=Abstract). - Chen, R. D. [Chemoprevention of cervical cancer--intervention study of cervical precancerous lesions by Zhonghua Zhong.Liu Za Zhi 1993;15:272-274. [View abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8174465&dopt=Abstract). - Bates, C. J., Prentice, A. M., and Paul, A. A. Seasonal variations in vitamins A, C, riboflavin and folate intakes and status of pregnant and lactating women in a rural Gambian community: some possible implications. Clin Nutr 1994;48:660-668. van, Dokkum W., Wedel, M., Schrijver, J., and Van den Berg, H. Thiamin, riboflavin and vitamin B6: impact of restricted intake on physical performance in man. J Am Coll Nutr 1994;13:629-640. [View abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7706598&dopt=Abstract). - Trygg, K., Lund-Larsen, B., Hoffman, H. J., Jacobsen, G., and Bakketeig, L. S. Do pregnant smokers eat differently from pregnant non-smokers? Paediatr.Perinat.Epidemiol 1995;9:307-319. [View abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7479279&dopt=Abstract). - Benton, D., Haller, J., and Fordy, J. Vitamin supplementation for 1 year improves mood. Neuropsychobiology 1995;32:98-105. [View - Cherstvova, L. in iron deficiency anemia]. Gematol.Transfuziol. 1984;29:47-50. [View abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=6381219&dopt=Abstract). - Bates, C. J., Flewitt, A., Prentice, A. M., Lamb, W. H., and Whitehead, R. G. Efficacy of a riboflavin supplement given at fortnightly intervals to pregnant and lactating women in rural Gambia. Hum.Nutr Clin Nutr 1983;37:427-432. - Bamji, supplements. V., and Radhaiah, G. Relationship between biochemical and clinical indices of B-vitamin deficiency. A study in rural school boys. Br J Nutr 1979;41:431-441. [View abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=465434&dopt=Abstract). - Hovi, L., Hekali, R., M. A. Evidence of riboflavin depletion in breast-fed newborns and its further acceleration during of hyperbilirubinemia by phototherapy. Acta Paediatr.Scand. 1979;68:567-570. [View abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=463539&dopt=Abstract). Hittelman, J., Burdige, J., and Wong, S. L. Postnatal decline in pyridoxal phosphate and riboflavin. Accentuation by J Dis Child 1985;139:812-815. [View abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=4040702&dopt=Abstract). - Holmlund, D. and Sjodin, J. G. colic with intravenous indomethacin. J Urol. 1978;120:676-677. [View abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=366182&dopt=Abstract). - Powers, H. J., Bates, C. J., Eccles, M., Brown, H., and George, E. Bicycling performance in Gambian children: effects of supplements of riboflavin or Pinto, J. R. S. Drugs that promote renal excretion of riboflavin. Nutr Interact. 1987;5:143-151. [View N., J. B., Thurnham, D. I., Crespi, M., and Bosch, F. X. Blood, retinol and zinc riboflavin status in relation to precancerous lesions of the esophagus: findings from a vitamin intervention trial in the People's Republic of China. Cancer Res 4-15-1988;48:2280-2283. [View abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=3280125&dopt=Abstract). - Lin, P. Z., Zhang, J. S., Cao, S. G., Rong, Z. P., Gao, R. Q., Han, R., and Shu, S. P. [Secondary prevention of esophageal cancer--intervention on precancerous lesions Zhonghua 1988;10:161-166. abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=3219974&dopt=Abstract). van, W., Schrijver, J., Wedel, M., Gaillard, A. W., Wesstra, A., van de Weerd, H., and Hermus, R. J. Thiamin, riboflavin, and vitamins B-6 and C: impact of combined restricted intake on functional performance in man. Am J Clin Nutr 1988;48:1451-1462. [View abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=3202095&dopt=Abstract). Polakov, B. I., Boyle, P., and Blettner, M. Chemoprevention of oral and esophageal cancer in Uzbekistan, Union of Soviet Socialist Republics. Natl.Cancer Inst.Monogr 1985;69:259-262. [View abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=2939349&dopt=Abstract). - L. J., Crespi, M., Thurnham, D. I., Day, N. E., Ji, Z. H., Grassi, A., Yan, L. W., Lin, L. G., and . No effect of riboflavine, retinol, and zinc on prevalence of precancerous lesions of oesophagus. Randomised double-blind intervention study in high-risk population of China. Lancet 7-20-1985;2:111-114. [View abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=2862315&dopt=Abstract). - Wang, Z. Y. [Chemoprevention in the high incidence area of lung cancer]. Zhonghua Zhong.Liu Za Zhi 1989;11:207-210. K., Baquet, C., and Gamshadzahi, A. Diet, nutritional status, and cancer risk in American blacks. Nutr Cancer 1989;12:1-28. [View abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=2652094&dopt=Abstract). - Desai, I. D., Doell, A. M., Officiati, S. A., Bianco, A. M., Van, Severen Y., Desai, M. I., Jansen, E., and de Oliveira, J. E. Nutritional needs assessment of rural agricultural migrants of southern Brazil: designing, implementing and evaluating a nutrition education program. World Rev.Nutr Diet. 1990;61:64-131. [View abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=2408256&dopt=Abstract). - Suboticanec, K., R. Effects of pyridoxine and riboflavin supplementation on physical fitness in young adolescents. Int J Vitam.Nutr Res. 1990;60:81-88. [View abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=2387675&dopt=Abstract). - Turkki, P. R., Ingerman, L., Schroeder, L. A., Chung, R. S., Chen, M., Russo-McGraw, M. A., and Dearlove, J. Riboflavin intakes and status of morbidly obese females during the Coll precancerous lesions of the esophagus--3 and 5 year inhibitory effect antitumor [View abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=2147582&dopt=Abstract). - Lin, P., Zhang, J., Rong, Z., Han, R., Xu, S., Gao, R., Ding, Z., Wang, J., Feng, H., and Cao, S. Studies on medicamentous inhibitory therapy for esophageal precancerous R. I., Anyanechi, C. C., and Krawinkel, M. B. Supplementary vitamin E, selenium, cysteine and riboflavin for preventing kwashiorkor in preschool countries. Cochrane.Database.Syst.Rev. 2010;:CD008147. [View abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=20393967&dopt=Abstract). - Koller, T., Mrochen, M., and Seiler, T. Complication and failure rates after corneal crosslinking. J Cataract Refract.Surg. 2009;35:1358-1362. [View abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=19631120&dopt=Abstract). - MacLennan, S. C., Wade, F. M., Forrest, K. M., Ratanayake, P. D., Fagan, E., and Antony, J. Wittig-Silva, C., Whiting, M., Lamoureux, E., Lindsay, R. G., Sullivan, L. J., and Snibson, G. R. A randomized controlled trial of corneal collagen cross-linking in progressive keratoconus: preliminary results. J Refract.Surg. 2008;24:S720-S725. [View abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=18811118&dopt=Abstract). - Ma, A. G., Schouten, E. G., Zhang, F. Z., Kok, F. J., Yang, F., Jiang, D. C., Sun, Y. Y., and Han, X. X. Retinol and riboflavin supplementation decreases the prevalence of anemia in Chinese pregnant women taking iron and folic Acid supplements. J Nutr 2008;138:1946-1950. [View abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=18806105&dopt=Abstract). - Liu, G., Lu, C., Yao, S., Zhao, F., Li, Y., Meng, X., Gao, J., Cai, J., Zhang, L., and Chen, Z. Radiosensitization mechanism of riboflavin in vitro. Sci China C.Life Sci 2002;45:344-352. [View abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=18759021&dopt=Abstract). - Figueiredo, J. C., Levine, A. J., Grau, M. V., Midttun, O., Ueland, P. M., Ahnen, D. J., Barry, E. L., Tsang, S., Munroe, D., Ali, I., Haile, R. W., Sandler, R. S., and Baron, J. A. Vitamins B2, B6, and B12 and risk of new colorectal adenomas in a randomized trial of aspirin McNulty, and Scott, J. M. Intake and status of folate and related B-vitamins: considerations and challenges in achieving Q10, niacin on alteration of DNA repair enzyme and DNA methylation in breast cancer patients Klin [View abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=18293264&dopt=Abstract). - Lynch, S. Influence of infection/inflammation, thalassemia and nutritional status on iron absorption. Int J Vitam.Nutr Res 2007;77:217-223. [View abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=18214023&dopt=Abstract). - Fischer Walker, C. L., Baqui, A. H., Ahmed, S., Zaman, K., El, Arifeen S., Begum, N., Yunus, M., Black, R. E., and Caulfield, L. E. Low-dose weekly supplementation of iron and/or zinc does not affect growth among Bangladeshi infants. Eur.J Clin Nutr 2009;63:87-92. V. factor-alpha and vascular endothelial growth factor in breast cancer patients treated with tamoxifen and supplemented with Kawanishi, S. Photosensitized DNA damage induced by NADH: site specificity and mechanism. Free Radic.Res 2007;41:461-468. Srihari, Kurpad, A. V., and Seshadri, S. Nutritional status of affluent Indian school children: what and how much do we know? Indian Pediatr. [View abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17413196&dopt=Abstract). - 2007;61:1237-1240. abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17299470&dopt=Abstract). - Singh, A., Moses, F. M., and Deuster, P. A. Vitamin and mineral status in physically active men: effects of a high-potency supplement. Am J G., Sachdanandam, of coenzyme Q10, riboflavin and niacin on serum CEA and CA 15-3 levels in breast cancer patients undergoing tamoxifen therapy. Caporossi, T. Parasurgical therapy for keratoconus by riboflavin-ultraviolet type A rays induced cross-linking of corneal collagen: preliminary refractive results in an Italian study. J Cataract 2006;32:837-845. abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16765803&dopt=Abstract). A., Zeviani, M., and Uziel, G. Effects of riboflavin in children with complex II deficiency. Brain Dev 2006;28:576-581. [View abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16737791&dopt=Abstract). - Neugebauer, H., Dowey le, R. C., Strain, J. J., Dunne, A., Ward, M., Molloy, A. M., McAnena, L. B., Hughes, J. P., Hannon-Fletcher, M., and Scott, J. M. Riboflavin lowers homocysteine in Riboflavin deficiency and esophageal cancer: a case control-household study in the Caspian Littoral of Iran. Cancer Detect.Prev 2005;29:464-469. [View abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16183212&dopt=Abstract). - Sandor, S. and Afra, of migraine. Curr D., Manary, prevention of kwashiorkor in blind, placebo controlled 5-14-2005;330:1109. [View abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15851401&dopt=Abstract). - Strain, J. J., Dowey, M., Pentieva, K., and McNulty, J. T. Homocysteine and cardiovascular nutrition, genetics and lifestyle. Can.J Appl.Physiol 2004;29:773-780. [View abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15630149&dopt=Abstract). - Macdonald, H. M., McGuigan, F. E., Fraser, W. D., New, S. A., Ralston, S. H., and Reid, D. M. Methylenetetrahydrofolate reductase polymorphism interacts with riboflavin intake to density. Bone 2004;35:957-964. [View abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15454103&dopt=Abstract). - Bwibo, N. O. and Neumann, C. G. The need for animal source foods by Kenyan children. J Nutr 2003;133(11 Suppl 2):3936S-3940S. [View abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14672293&dopt=Abstract). - Park, Y. H., de Groot, L. C., and van Staveren, W. A. Dietary intake and anthropometry of Korean elderly people: a literature review. Asia Pac.J Clin Nutr 2003;12:234-242. [View abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14505983&dopt=Abstract). - Dyer, A. R., Elliott, P., Stamler, J., Chan, Q., Ueshima, H., and Zhou, B. F. Dietary intake in male and female smokers, ex-smokers, and never smokers: the INTERMAP study. J Hum.Hypertens. 2003;17:641-654. [View abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=13679954&dopt=Abstract). - Powers, H. J. Riboflavin health. Am J Clin Nutr 2003;77:1352-1360. [View abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12791609&dopt=Abstract). - Hunt, I. F., Jacob, M., Ostegard, N. J., Masri, G., Clark, V. A., and Coulson, A. H. Effect of nutrition education on the nutritional status of low-income pregnant women of Mexican descent. Am J Clin Nutr 1976;29:675-684. [View abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=1274890&dopt=Abstract). - T. Riboflavin/ultraviolet-a-induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol. 2003;135:620-627. [View abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12719068&dopt=Abstract). - Navarro, M. and Wood, R. J. Plasma changes in micronutrients following a multivitamin and mineral supplement in healthy adults. J Am Coll Nutr 2003;22:124-132. [View abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12672708&dopt=Abstract). - Moat, S. J., Ashfield-Watt, P. A., Powers, H. J., Newcombe, R. G., and McDowell, I. F. Effect of riboflavin status on the homocysteine-lowering effect of folate in linking]. Ophthalmologe K., McNulty, H., Seljeflot, I., and Strandjord, R. E. The effect of B-vitamins on hyperhomocysteinemia in patients on antiepileptic drugs. Epilepsy Res [View - Hustad, S., McKinley, M. C., McNulty, H., Schneede, J., Strain, J. J., Scott, J. M., and Ueland, P. M. Riboflavin, flavin mononucleotide, and flavin adenine dinucleotide M. C., Wilson, B., McPartlin, J., Strain, J. J., Weir, D. G., and Scott, J. M. Impaired functioning of thermolabile methylenetetrahydrofolate reductase is dependent on riboflavin J Clin Nutr 2002;76:436-441. [View abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12145019&dopt=Abstract). - Yoon, H. R., Hahn, S. H., Ahn, Y. M., Jang, S. H., Shin, Y. J., Lee, E. H., Ryu, K. H., Eun, B. L., Rinaldo, P., and Yamaguchi, S. Therapeutic trial in the first three Asian cases of ethylmalonic encephalopathy: response to riboflavin. J Inherit.Metab Dis 2001;24:870-873. [View abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11916321&dopt=Abstract). - Ding, Z., Gao, F., and Lin, P. [Long-term effect of treating patients with precancerous lesions of the esophagus]. Zhonghua Zhong.Liu Za Zhi 1999;21:275-277. [View abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11776814&dopt=Abstract). - Lin, P., Chen, Z., Hou, J., Liu, T., and Wang, J. [Chemoprevention of esophageal cancer]. P., Lara, J., Romero-Keith, J., Castorena, G., Villa, A. R., Lopez, N., Pedraza, J., Medina, O., Rodriguez, C., Chavez-Peon, Medina F., and James, W. P. Nutrition and cataract in low-income Mexicans: experience in an Eye camp. Arch.Latinoam.Nutr 2001;51:113-121. [View abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11678042&dopt=Abstract). - Head, K. A. Natural therapies part two: cataracts P. J., and Lipton, R. B. Management of S. E., Zhang, Y., Bjorke-Monsen, A. L., and Schneede, J. Riboflavin as a determinant of plasma total Taylor, P. R., Li, B., Dawsey, S. M., Li, J. Y., Yang, C. S., Guo, W., and Blot, W. J. Prevention of esophageal cancer: the nutrition intervention trials in Linxian, China. Linxian Nutrition Intervention Trials Study Group. Cancer Res 4-1-1994;54(7 Suppl):2029s-2031s. [View abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8137333&dopt=Abstract). - Blot, W. J., Li, J. Y., Taylor, P. R., Guo, W., Dawsey, S. M., and Li, B. The Linxian trials: mortality rates by vitamin-mineral 1995;62(6 Suppl):1424S-1426S. [View abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7495242&dopt=Abstract). - Qu, C. X., Kamangar, F., Fan, J. H., Yu, B., Sun, X. D., Taylor, P. R., Chen, B. E., Abnet, C. C., Qiao, Y. L., Mark, S. D., and Dawsey, S. M. Chemoprevention of primary liver cancer: a 8-15-2007;99:1240-1247. abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17686823&dopt=Abstract). - Bates, C. J., Evans, P. H., Allison, G., Sonko, B. J., Hoare, S., Goodrich, S., and Aspray, T. Biochemical indices and neuromuscular function tests in rural Gambian schoolchildren given a riboflavin, or multivitamin plus iron, supplement. Pholpothi, T., and Schelp, F. P. The effect of riboflavin on the hematologic changes in iron supplementation of schoolchildren. Southeast Asian J.Trop.Med.Public Health 1980;11:97-103. [View abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=6996113&dopt=Abstract). - Powers, H. J., Bates, C. J., Prentice, A. M., Lamb, W. H., Jepson, M., and Bowman, H. The relative effectiveness of iron and iron with riboflavin in correcting a microcytic anaemia in men and children in rural Gambia. Hum.Nutr.Clin.Nutr. 1983;37:413-425. [View abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=6668226&dopt=Abstract). - Bates, C. J., Powers, H. J., Lamb, W. H., Gelman, W., and Webb, E. Effect of supplementary vitamins and iron on malaria indices in rural Gambian children. Trans.R.Soc.Trop.Med.Hyg. 1987;81:286-291. [View abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=3617193&dopt=Abstract). - Kabat, G. C., Miller, A. B., Jain, M., and Rohan, T. E. Dietary intake of selected B vitamins in relation to risk of major cancers in women. Br.J.Cancer 9-2-2008;99:816-821. [View abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=18665162&dopt=Abstract). - McNulty, 2008;67:232-237. [View abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=18412997&dopt=Abstract). D. J., MacIntosh, G., Lowe, G. D., Rumley, A., McMahon, A. D., Langhorne, P., Tait, R. C., O'Reilly, D. S., Spilg, E. G., MacDonald, J. B., MacFarlane, P. W., and Westendorp, R. G. Randomized controlled trial of homocysteine-lowering vitamin treatment in elderly patients vascular disease. 2005;82:1320-1326. [View abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16332666&dopt=Abstract). P. Anti-angiogenic potential of CoenzymeQ10, riboflavin and niacin Vascul.Pharmacol. 2008;48(4-6):191-201. [View abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=18407793&dopt=Abstract). - Tepper, S. J. Complementary and alternative treatments for childhood headaches. Curr Pain Headache Rep. 2008;12:379-383. [View abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=18765145&dopt=Abstract). - Kamangar, F., Qiao, Y. L., Yu, B., Sun, X. D., Abnet, C. C., Fan, J. H., Mark, S. D., Zhao, P., Dawsey, S. M., and Taylor, P. R. Lung cancer chemoprevention: a randomized, double-blind - Sun-Edelstein, C. and Mauskop, A. Foods and supplements in the management of migraine headaches. Clin J Pain 2009;25:446-452. [View abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=19454881&dopt=Abstract). - phenobarbital and 3-methylcholanthrene et al. Riboflavin deficiency and iron absorption in adult Gambian men. T, Davenport W, Mackie G, et al. Canadian Headache Society guideline for migraine prophylaxis. Can J Neurol.Sci 2012;39:S1-59. [View abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=22683887&dopt=Abstract). et al. Evidence-based guideline update: NSAIDs and other complementary treatments for episodic migraine prevention in adults: Report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology 2012;78:1346-53. [View abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=22529203&dopt=Abstract). - Jacques PF, Taylor A, Moeller S, et al. Long-term nutrient intake and 5-year change in nuclear lens opacities. Arch 2005;123:517-26. [View abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15824226&dopt=Abstract). - Maizels riboflavin, magnesium, and Reuter U, Flach U, al. High-dose riboflavin treatment is efficacious in migraine prophylaxis: an open study in a tertiary care centre. Eur J Neurol 2004;11:475-7. [View abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15257686&dopt=Abstract). - Sandor PS, Di Clemente L, et al. Efficacy of coenzyme Hernandez BY, McDuffie K, Wilkens LR, et al. Diet and premalignant lesions of the cervix: evidence of a protective role for folate, riboflavin, thiamin, and vitamin al. Brief communication. Vitamin B1, B2, and B6 augmentation of tricyclic antidepressant treatment in geriatric depression J Coll abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=1578091&dopt=Abstract). - et al. Selected micronutrients and oral and pharyngeal cancer. Int J Cancer 2000;86:122-7.. [View abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10728605&dopt=Abstract). - Vir SC, Love AH. Riboflavin nutriture users. Vitam Nutr 1979;49:286-90.. [View abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=528155&dopt=Abstract). H, Obara K. Induction of the FAD synthetase system in rat liver by phenobarbital administration. Int J Vit Nutr Res 1979;49:59-63.. Ohkawa H, of the 7- and 8-methyl groups of riboflavin by the microsomal electron transfer system of rat liver. J Biol Chem 1983;258:5629-33.. [View abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=6853536&dopt=Abstract). inhibits synthesis relation cardiotoxicity anthracyclines Clin - J. et al. Riboflavin deficiency caused by with adriamycin. J Nutr Sci Vitaminol 1991;37:473-7.. [View abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=1802973&dopt=Abstract). - Lewis CM, King JC. Effect of oral contraceptive agents on thiamin, riboflavin, and pantothenic acid status in young women. Am Clin Nutr 1980;33:832-8.. [View abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7361702&dopt=Abstract). - Roe DA, Bogusz S, Sheu J, et al. Factors affecting riboflavin requirements of oral contraceptive users and non-users. Am J Clin Nutr 1982;35:495-501.. [View abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7064900&dopt=Abstract). - Newman LJ, Lopez R, Cole HS, et al. Riboflavin deficiency in women taking oral contraceptive agents. Am J Clin Nutr 1978;31:247-9.. [View abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=623047&dopt=Abstract). - Briggs M. Oral contraceptives and vitamin nutrition (letter). Lancet 1974;1:1234-5. [View abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=4134706&dopt=Abstract). - Ahmed F, Bamji MS, Iyengar L. Effect of oral contraceptive agents on vitamin nutrition status. Am J Clin Nutr 1975;28:606-15.. J, Huang YP, Rivlin RS. Accelerated development Cardiac sensitivity to the inhibitory effects of chlorpromazine, metabolism rat of on riboflavin absorption excretion in man. J abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=6049701&dopt=Abstract). N, Shih OD, Riboflavin transport by isolated perfused [View Dalton SD, Rahimi AR. Emerging role of riboflavin in the treatment of nucleoside analogue-induced type AIDS [View abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11788075&dopt=Abstract). - Roe DA, Kalkwarf H, Stevens J. Effect of fiber supplements on the apparent absorption of pharmacological doses of riboflavin. J Am Diet Assoc Raiczyk GB, Huang YP, Rivlin RS. New approaches to the possible prevention of side effects of chemotherapy by nutrition. Cancer 1986;58:1911-4.. [View abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=3756811&dopt=Abstract). - McCormick DB. Riboflavin. In: Shils ME, Olson JA, Shike M, Ross AC, eds. Modern Nutrition in Health and Disease. 9th ed. Baltimore, MD: Williams & Wilkins, 1999. pg.391-9. - Fishman SM, Christian P, West KP. The role of vitamins in the prevention and control of anaemia. Public Health Nutr 2000;3:125-50.. [View abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10948381&dopt=Abstract). - - Sazawal S, Black RE, Menon VP, et al. Zinc supplementation in infants born small for gestational age reduces mortality: a prospective, randomized, controlled trial. Pediatrics 2001;108:1280-6. [View abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11731649&dopt=Abstract). - Cumming RG, Mitchell P, Smith W. Diet and cataract: the Blue Mountains Eye Study. Ophthalmology 2000;10:450-6. [View abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10711880&dopt=Abstract). - Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes for Thiamin, Press, 2000. Available at: with nucleoside analogues. Natl AIDS Treatment Advocacy Project. Dig Disease Week Liver Conf, San Diego,CA. 2000;May 21-4:Rep11. - Electronic Code of Federal Regulations. Title 21. Part 182 -- Substances Generally Recognized As Safe. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=182 - Sperduto RD, Hu TS, Milton RC, et al. The Linxian cataract studies. Two nutrition intervention trials. Arch Ophthalmol abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8363468&dopt=Abstract). - Wang of vitamin/mineral supplementation on the prevalence of histological dysplasia and early cancer of the esophagus and stomach: results from the General Population Trial [View abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=797497&dopt=Abstract). - Sanpitak nutrition. Lancet 1974;1:836-7. [View abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=4132791&dopt=Abstract). - Hill MJ. Intestinal flora and synthesis. Eur J Cancer Prev 1997;6:S43-5. [View abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9167138&dopt=Abstract). - Yates AA, Schlicker SA, Suitor CW. Dietary reference intakes: The new basis for recommendations for calcium and related nutrients, B vitamins, and choline. J Am Diet Assoc 1998;98:699-706. [View abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9627630&dopt=Abstract). - Kastrup EK. Drug Facts and Comparisons. 1998 ed. St. Louis, MO: Facts and Comparisons, 1998. - Mark SD, Wang W, Fraumeni JF Jr, et al. Do nutritional supplements lower the risk of stroke or hypertension? Epidemiology 1998;9:9-15. [View abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9430262&dopt=Abstract). - Blot WJ, Li PR. intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. J Natl Cancer as a prophylactic treatment of migraine: of an open pilot study. Cephalalgia 1994;14:328-9. [View abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7828189&dopt=Abstract). - Sandor PS, Prophylactic treatment of migraine with beta-blockers and riboflavin: differential effects on the intensity dependence of auditory evoked cortical potentials. Headache 2000;40:30-5. [View abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10759900&dopt=Abstract). - Kunsman GW, Levine Smith ML. Vitamin B2 interference with TDx drugs-of-abuse assays. J Forensic Sci 1998;43:1225-7. [View abstract](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9846401&dopt=Abstract). - Gupta SK, Gupta RC, Seth AK, Gupta A. Reversal of fluorosis Goodman and Gillman's The Pharmacological Basis of Therapeutics, 9th ed. New York, NY: McGraw-Hill, 1996. - Young DS. Effects of Drugs on Clinical Laboratory Tests 4th ed. Washington: AACC Press, 1995. - McEvoy GK, ed. AHFS Drug Information. Bethesda, MD: American Society of Health-System Pharmacists, 1998. - Foster S, Tyler VE. Tyler's Honest Herbal: A Sensible Guide to the Use of Herbs and Related Remedies. 3rd ed., Binghamton, NY: Haworth Herbal Press, 1993. - Newall CA, Anderson LA, Philpson JD. Herbal Medicine: A Guide for Healthcare Professionals. London, UK: The Pharmaceutical Press, 1996. - Tyler VE. Herbs of Choice. Binghamton, NY: Pharmaceutical Products Press, 1994. - Blumenthal M, ed. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. Trans. S. Klein. Boston, MA: American Botanical Council, 1998. - Monographs on the medicinal uses of plant drugs. Exeter, UK: European Scientific Co-op Phytother, "}